ABOUT US
The BioReliance® contract testing portfolio provides best-in-class biosafety testing and analytical development methods for both traditional and novel therapies. This work is critical to ensure the safety of medicines. Currently, about 800 employees work at the Rockville site.
WE’RE EXPANDING IN 2024!
A new state-of-the-art, 23,000-square-meter facility will house biosafety testing, analytical development, viral clearance suites, and cell bank manufacturing services. Over the next four years, the expansion will create more than 500 new jobs.